Friedrich Daniel von Recklinghausen coined the term haemochromatosis in 1889, establishing the critical link between the condition and iron accumulation in bodily tissues. A central figure in 19th-century German pathology, his research spanned the intricate mechanics of cell junctions, lymphatic systems, and the systematic description of skeletal disorders that bear his name in contemporary medical literature.
Academic Formation and Early Career
Born in 1833 in Gütersloh, Recklinghausen pursued medical studies starting in 1852 at the universities of Bonn, Würzburg, and Berlin. He earned his doctorate in 1855, completing an inaugural thesis on pyaemia. Under the mentorship of Rudolf Virchow in Berlin, he focused on pathological anatomy, later conducting observations in Vienna, Rome, and Paris. From 1858 until 1864, he served as an assistant at the Pathological Institute in Berlin, where he pioneered a silver-staining method to delineate cell junction lines, a technique that subsequently facilitated studies on leukocyte migration and inflammation.
Twenty questions, eight minutes on the clock, and a percentile measured against everyone who has taken it. No sign-up.
Take the IQ test →Professorships and Clinical Research
In 1864, Recklinghausen was appointed professor of pathological anatomy at Königsberg. Six months later, he moved to Würzburg, where he taught until 1872. That year, he accepted a position as professor of general pathology and pathological anatomy at the University of Strasbourg. Throughout his tenure at Strasbourg, he served as dean of the medical faculty and rector of the university. He remained an active researcher and teacher there until his death in 1910.
Contributions to Pathological Classification
Recklinghausen’s clinical output was extensive. In 1882, he published a seminal monograph classifying neurofibromatosis type I, identifying the tumors as neurofibromas composed of nerve cells and fibrous tissue. His 1891 systematic description of Osteitis fibrosa cystica remains a hallmark of his diagnostic work. Beyond these, he provided an account of spina bifida in 1886 and explored the relationships between osteomalacia and rickets in his final years. His posthumously published monograph introduced the term oncosis to describe ischemic cell death.
Fast facts
- Born: 1833, Gütersloh, Kingdom of Prussia
- Died: 1910, Strasbourg
- Education: Humboldt-Universität zu Berlin, University of Bonn, University of Würzburg
- Key Term Coined: Haemochromatosis (1889)
- Notable Condition: Neurofibromatosis type I
- Professional Member: Royal Prussian Academy of Sciences, American Academy of Arts and Sciences
- Notable Technique: Silver staining of cell junctions
Questions readers ask
What is von Recklinghausen's disease?
The term historically refers to neurofibromatosis type I, characterized by neurofibromas, though it was also used to describe Osteitis fibrosa cystica.
What did Recklinghausen contribute to understanding cell biology?
He developed a silver-staining method to visualize cell junctions and identified granular cells in the frog mesentery, which were later identified as mast cells.
Achievements
- Held posts at University of Würzburg, University of Königsberg and University of Strasbourg
- Fields: anatomical pathology, medicine and pathology
